SCHEMBL7046359

SCHEMBL7046359

N#Cc1cc(C(=O)CC(=O)Nc2cc(C(F)(F)F)c(N3CCOCC3)cc2NC(=O)O)ccn1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
THRB P10828 1/20 0.42
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
KMT2A Q03164 1/20 0.39
RAF1 P04049 5/20 0.39
BRAF P15056 5/20 0.39
ALDH1A1 P00352 5/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 2/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6612631 0.92 SCN10A (0.42) KDM4ESMN1; SMN2LMNAMAPTNPSR1
SCHEMBL6608517 0.92 SCN10A (0.40) KDM4ESMN1; SMN2LMNATHRBMAPT
SCHEMBL6435489 0.90 THRB (0.41) KDM4ESMN1; SMN2LMNATHRBJAK2
SCHEMBL6163340 0.82 SCN10A (0.37) SMN1; SMN2THRBJAK3MAPTNPSR1
SCHEMBL6165622 0.82 SCN10A (0.39) SMN1; SMN2JAK3MAPTNPSR1
SCHEMBL6609589 0.81 MAPT (0.38) KMT2AALDH1A1GAAHPGDMAPT
SCHEMBL6435938 0.80 KDR (0.34) LMNATHRBJAK2JAK3
SCHEMBL6610697 0.79 POLB (0.39) SMN1; SMN2KMT2AALDH1A1
SCHEMBL6685456 0.79 CHEK1 (0.38) KDM4ESMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL6607218 0.78 BDKRB1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379522-A1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 EP disclosed
WO-2002083665-A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I F. HOFFMANN-LA ROCHE AG (CH) 2002-10-24 WO disclosed